General Information
Version
8.5
Revision date
2023-12-25
Product name
Human Leptin ELISA Kit (BULK PACK)
REACH No
This
Emergency telephone
+33 (0)9 75 18 14 07 (CHEMTREC
Icons in SDS
Company Information
company name
Merck Life Science S.A.S
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H290, H317
Hazard statements
Code
Statements
H290
May be corrosive to metals
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Corrosive to Metals, (Category 1) H290: May be corrosive to metals. Skin sensitization, (Category 1) H317: May cause an allergic skin reaction.
2.2 Label elements
Labelling
Signal word
Warning Warning
Hazard statements
H290 May be corrosive to metals. H317 May cause an allergic skin reaction. Reduced Labeling (<= 125 ml) H317 May cause an allergic skin reaction.
Precautionary statements
P234 Keep only in original packaging. P261 Avoid breathing mist or vapors. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of water. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P261 Avoid breathing mist or vapors. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of water. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.